PolyPid (PYPD) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on PolyPid (PYPD) is Neutral.

The composite score behind that read is -0.15, weighing +0.29 of bullish evidence against -0.41 bearish.

PolyPid last closed at $5.07, +3.47% on the session.

Against the IVW growth benchmark the position is +2.67% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for PYPD so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks PolyPid in the 3rd percentile on return on equity, where 100 is best.

PolyPid is classified under Health Care / Pharmaceuticals, with a market capitalisation of $99.53M.

StockMap tracks PolyPid as the 102nd largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite PolyPid ranks 96th of 151 in the group, against a group median of -0.08.